Achieve Life Sciences, Inc. (FRA:SP4P)
Germany flag Germany · Delayed Price · Currency is EUR
3.640
+0.150 (4.30%)
At close: Feb 20, 2026

Achieve Life Sciences Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
19311779416540
Market Cap Growth
73.43%48.21%92.29%-36.56%62.97%301.51%
Enterprise Value
1618576393522
Last Close Price
3.643.563.702.356.606.30
PB Ratio
6.735.79-60.225.282.621.30
P/TBV Ratio
7.126.41-7.492.901.41
Debt / Equity Ratio
0.300.48-11.551.950.540.00
Net Debt / Equity Ratio
-1.13-1.17-0.82-1.03-1.00-0.96
Net Debt / EBITDA Ratio
0.730.63-0.040.210.852.47
Net Debt / FCF Ratio
0.940.82-0.050.230.952.65
Quick Ratio
4.955.140.751.159.4912.22
Current Ratio
5.145.460.821.269.8012.60
Return on Equity (ROE)
-161.08%-409.51%-869.88%-233.04%-101.49%-53.24%
Return on Assets (ROA)
-65.45%-84.19%-69.03%-65.82%-47.11%-30.04%
Return on Capital Employed (ROCE)
-123.70%-122.30%1889.70%-487.30%-77.00%-39.50%
Earnings Yield
-23.12%-32.90%-34.19%-96.58%-45.07%-30.35%
FCF Yield
--24.59%-28.09%-85.68%-40.03%-27.79%
Buyback Yield / Dilution
-34.94%-61.75%-87.17%-30.46%-198.64%-559.42%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.